Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

TIL

Instill Bio (TIL)

Instill Bio Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:TIL
日付受信時刻ニュースソース見出しコード企業名
2024/03/2206 : 00GlobeNewswire Inc.Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
2024/02/1506 : 08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
2024/02/1407 : 36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TILInstill Bio Inc
2024/01/1821 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
2024/01/1707 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
2024/01/1622 : 00GlobeNewswire Inc.Instil Bio Announces Strategic UpdateNASDAQ:TILInstill Bio Inc
2024/01/1110 : 10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TILInstill Bio Inc
2024/01/1109 : 49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TILInstill Bio Inc
2023/12/0907 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
2023/12/0607 : 00GlobeNewswire Inc.Instil Bio Announces Effective Date of 1-for-20 Reverse Stock SplitNASDAQ:TILInstill Bio Inc
2023/11/2721 : 13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
2023/11/1407 : 27Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:TILInstill Bio Inc
2023/11/1407 : 03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TILInstill Bio Inc
2023/11/1407 : 00GlobeNewswire Inc.Instil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
2023/11/1407 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
2023/11/0621 : 00GlobeNewswire Inc.Instil Bio Announces Poster Presentations of ITIL-306 Preclinical Data at SITC 2023 Annual MeetingNASDAQ:TILInstill Bio Inc
2023/08/1420 : 05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TILInstill Bio Inc
2023/08/1420 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
2023/08/1420 : 00GlobeNewswire Inc.Instil Bio Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
2023/06/2705 : 38GlobeNewswire Inc.Instil Bio Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual ConferenceNASDAQ:TILInstill Bio Inc
2023/06/2705 : 33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
2023/06/1505 : 32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
2023/05/1120 : 06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
2023/05/1120 : 00GlobeNewswire Inc.Instil Bio Reports First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
2023/04/2905 : 37Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:TILInstill Bio Inc
2023/04/2505 : 31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TILInstill Bio Inc
2023/04/1022 : 38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TILInstill Bio Inc
2023/03/3120 : 40Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TILInstill Bio Inc
2023/03/3120 : 08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
2023/03/3120 : 00GlobeNewswire Inc.Instil Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
 Showing the most relevant articles for your search:NASDAQ:TIL

最近閲覧した銘柄